Skip to main content
    • Aa
    • Aa

Molecular mechanisms of endothelial hyperpermeability: implications in inflammation

  • Puneet Kumar (a1), Qiang Shen (a1), Christopher D. Pivetti (a1), Eugene S. Lee (a1), Mack H. Wu (a1) and Sarah Y. Yuan (a1)...

Endothelial hyperpermeability is a significant problem in vascular inflammation associated with trauma, ischaemia–reperfusion injury, sepsis, adult respiratory distress syndrome, diabetes, thrombosis and cancer. An important mechanism underlying this process is increased paracellular leakage of plasma fluid and protein. Inflammatory stimuli such as histamine, thrombin, vascular endothelial growth factor and activated neutrophils can cause dissociation of cell–cell junctions between endothelial cells as well as cytoskeleton contraction, leading to a widened intercellular space that facilitates transendothelial flux. Such structural changes initiate with agonist–receptor binding, followed by activation of intracellular signalling molecules including calcium, protein kinase C, tyrosine kinases, myosin light chain kinase, and small Rho-GTPases; these kinases and GTPases then phosphorylate or alter the conformation of different subcellular components that control cell–cell adhesion, resulting in paracellular hypermeability. Targeting key signalling molecules that mediate endothelial-junction–cytoskeleton dissociation demonstrates a therapeutic potential to improve vascular barrier function during inflammatory injury.

Corresponding author
*Corresponding author: Sarah Yuan, Department of Surgery, University of California Davis Medical Center, 4625 2nd Avenue, Room 3006, Sacramento, CA 95817, USA. Tel: +1 916 703 0422; Fax: +1 916 703 0421; E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1 P.M. Bauer (2005) Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 102, 204-209

2 J.P. Gratton , P. Bernatchez and W.C. Sessa (2004) Caveolae and caveolins in the cardiovascular system. Circulation Research 94, 1408-1417

3 M.I. Lin (2007) Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Research 67, 2849-2856

5 D. Mehta and A.B. Malik (2006) Signaling mechanisms regulating endothelial permeability. Physiological Reviews 86, 279-367

7 F.E. Curry and R.H. Adamson (1999) Transendothelial pathways in venular microvessels exposed to agents which increase permeability: the gaps in our knowledge. Microcirculation 6, 3-5

9 S. Iyer (2004) VE-cadherin-p120 interaction is required for maintenance of endothelial barrier function. American Journal of Physiology – Lung Cellular and Molecular Physiology 286, L1143-1153

10 K. Xiao (2005) p120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin. Molecular Biology of the Cell 16, 5141-5151

12 E. Dejana (2004) Endothelial cell-cell junctions: happy together. Nature Reviews Molecular Cell Biology 5, 261-270

13 C. Tiruppathi (2006) Ca2+ signaling, TRP channels, and endothelial permeability. Microcirculation 13, 693-708

14 S.Y. Yuan (2002) Protein kinase signaling in the modulation of microvascular permeability. Vascular Pharmacology 39, 213-223

15 S.Y. Yuan (2007) Microvascular permeability in diabetes and insulin resistance. Microcirculation 14, 363-373

16 M. Isshiki (1998) Endothelial Ca2+ waves preferentially originate at specific loci in caveolin-rich cell edges. Proceedings of the National Academy of Sciences of the United States of America 95, 5009-5014

17 M. Maekawa (1999) Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285, 895-898

18 D. Mehta , A. Rahman and A.B. Malik (2001) Protein kinase C-alpha signals rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function. Journal of Biological Chemistry 276, 22614-22620

20 J.E. Stasek Jr, C.E. Patterson and J.G. Garcia (1992) Protein kinase C phosphorylates caldesmon77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers. Journal of Cellular Physiology 153, 62-75

21 R. Sandoval (2001) Ca(2+) signalling and PKCalpha activate increased endothelial permeability by disassembly of VE-cadherin junctions. Journal of Physiology 533, 433-445

23 H. Aramoto (2004) Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation. American Journal of Physiology – Heart and Circulatory Physiology 287, H1590-1598

25 J.W. Breslin (2003) VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. American Journal of Physiology – Heart and Circulatory Physiology 284, H92-H100

26 B.K. Lal (2001) VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways. Microvascular Research 62, 252-262

27 S. Varma (2002) p42/44MAPK regulates baseline permeability and cGMP-induced hyperpermeability in endothelial cells. Microvascular Research 63, 172-178

29 R.A. Stockton , E. Schaefer and M.A. Schwartz (2004) p21-activated kinase regulates endothelial permeability through modulation of contractility. Journal of Biological Chemistry 279, 46621-46630

30 M.H. Wu (2003) Focal adhesion kinase mediates porcine venular hyperpermeability elicited by vascular endothelial growth factor. Journal of Physiology 552, 691-699

31 J. Gavard and J.S. Gutkind (2006) VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nature Cell Biology 8, 1223-1234

32 B.P. Eliceiri (1999) Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Molecular Cell 4, 915-924

33 K.G. Birukov (2001) Differential regulation of alternatively spliced endothelial cell myosin light chain kinase isoforms by p60(Src). Journal of Biological Chemistry 276, 8567-8573

34 M.H. Wu , E. Ustinova and H.J. Granger (2001) Integrin binding to fibronectin and vitronectin maintains the barrier function of isolated porcine coronary venules. Journal of Physiology 532, 785-791

35 A.N. Shajahan (2004) Role of Src-induced dynamin-2 phosphorylation in caveolae-mediated endocytosis in endothelial cells. Journal of Biological Chemistry 279, 20392-20400

37 A. Mammoto , T. Mammoto and D.E. Ingber (2008) Rho signaling and mechanical control of vascular development. Current Opinion in Hematology 15, 228-234

38 J.W. Breslin (2006) Involvement of ROCK-mediated endothelial tension development in neutrophil-stimulated microvascular leakage. American Journal of Physiology – Heart and Circulatory Physiology 290, H741-750

39 J.W. Breslin and S.Y. Yuan (2004) Involvement of RhoA and Rho kinase in neutrophil-stimulated endothelial hyperpermeability. American Journal of Physiology – Heart and Circulatory Physiology 286, H1057-1062

40 H. Sun (2006) Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability. Microcirculation 13, 237-247

41 G.P. van Nieuw Amerongen (2000) Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases. Circulation Research 87, 335-340

42 S.B. Patil and K.N. Bitar (2006) RhoA- and PKC-alpha-mediated phosphorylation of MYPT and its association with HSP27 in colonic smooth muscle cells. American Journal of Physiology – Gastrointestinal and Liver Physiology 290, G83-95

43 J.G. Garcia (2001) Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. Journal of Clinical Investigation 108, 689-701

44 F. Liu (2002) Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase-3beta. FASEB Journal 16, 950-962

45 P. Kouklis (2004) Cdc42 regulates the restoration of endothelial barrier function. Circulation Research 94, 159-166

47 M.G. Lampugnani (1991) The role of integrins in the maintenance of endothelial monolayer integrity. Journal of Cell Biology 112, 479-490

49 M.E. Parsons and C.R. Ganellin (2006) Histamine and its receptors. British Journal of Pharmacology 147 Suppl 1, S127-135

50 G.F. Clough , A.R. Bennett and M.K. Church (1998) Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging. British Journal of Dermatology 138, 806-814

51 S.Y. Yuan (2000) Signal transduction pathways in enhanced microvascular permeability. Microcirculation 7, 395-403

52 M.H. Wu , S.Y. Yuan and H.J. Granger (2005) The protein kinase MEK1/2 mediate vascular endothelial growth factor- and histamine-induced hyperpermeability in porcine coronary venules. Journal of Physiology 563, 95-104

53 M. Guo (2008) VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability. American Journal of Physiology - Cell Physiology 294, C977-984

54 D.M. Shasby (2002) Histamine stimulates phosphorylation of adherens junction proteins and alters their link to vimentin. American Journal of Physiology – Lung Cellular and Molecular Physiology 282, L1330-1338

56 T. Borbiev (2003) Role of CaM kinase II and ERK activation in thrombin-induced endothelial cell barrier dysfunction. American Journal of Physiology – Lung Cellular and Molecular Physiology 285, L43-54

57 A.A. Birukova (2004) Novel role of microtubules in thrombin-induced endothelial barrier dysfunction. FASEB Journal 18, 1879-1890

58 M. Holinstat (2003) Protein kinase Calpha-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement. Journal of Biological Chemistry 278, 28793-28798

59 R.J. Grand , A.S. Turnell and P.W. Grabham (1996) Cellular consequences of thrombin-receptor activation. The Biochemical Journal 313, 353-368

60 D.R. Senger (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985

61 S.M. Weis and D.A. Cheresh (2005) Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437, 497-504

62 H. Takahashi (2004) A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1. Journal of Biological Chemistry 279, 46304-46314

63 I. Zachary (2003) VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochemical Society Transactions 31, 1171-1177

65 M. Kelly , J.M. Hwang and P. Kubes (2007) Modulating leukocyte recruitment in inflammation. Journal of Allergy and Clinical Immunology 120, 3-10

66 P. Kubes (2002) The complexities of leukocyte recruitment. Seminars in Immunology 14, 65-72

67 Y. Liu (2004) Regulation of leukocyte transmigration: cell surface interactions and signaling events. Journal of Immunology 172, 7-13

68 R.M. Rao (2005) Emerging topics in the regulation of leukocyte transendothelial migration. Microcirculation 12, 83-89

69 R.M. Rao (2007) Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circulation Research 101, 234-247

70 A.R. Rosenkranz and T.N. Mayadas (1999) Leukocyte-endothelial cell interactions - lessons from knockout mice. Experimental Nephrology 7, 125-136

71 A. Zarbock and K. Ley (2008) Mechanisms and consequences of neutrophil interaction with the endothelium. American Journal of Pathology 172, 1-7

72 I.H. Sarelius (2006) Macromolecule permeability of in situ and excised rodent skeletal muscle arterioles and venules. American Journal of Physiology – Heart and Circulatory Physiology 290, H474-480

73 S.Y. Yuan (2002) Myosin light chain phosphorylation in neutrophil-stimulated coronary microvascular leakage. Circulation Research 90, 1214-1221

74 J.H. Tinsley (2002) Src-dependent, neutrophil-mediated vascular hyperpermeability and beta-catenin modification. American Journal of Physiology – Cell Physiology 283, C1745-1751

75 Y. Chiba (2001) Activation of rho is involved in the mechanism of hydrogen-peroxide-induced lung edema in isolated perfused rabbit lung. Microvascular Research 62, 164-171

76 R. Sumagin , E. Lomakina and I.H. Sarelius (2008) Leukocyte-endothelial cell interactions are linked to vascular permeability via ICAM-1-mediated signaling. American Journal of Physiology – Heart and Circulatory Physiology 295, H969-H977

77 P.V. Usatyuk (2003) Role of Ca2+ in diperoxovanadate-induced cytoskeletal remodeling and endothelial cell barrier function. American Journal of Physiology – Lung Cellular and Molecular Physiology 285, L1006-1017

78 P.V. Usatyuk (2003) Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells. Antioxidants and Redox Signalling 5, 723-730

79 T.S. Blackwell and J.W. Christman (1997) The role of nuclear factor-kappa B in cytokine gene regulation. American Journal of Respiratory Cell and Molecular Biology 17, 3-9

80 J. Reutershan and K. Ley (2004) Bench-to-bedside review: acute respiratory distress syndrome - how neutrophils migrate into the lung. Critical Care 8, 453-461

81 G. Hu (2008) Intercellular adhesion molecule-1-dependent neutrophil adhesion to endothelial cells induces caveolae-mediated pulmonary vascular hyperpermeability. Circulation Research 102, e120-131

82 M. Bhatia and S. Moochhala (2004) Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. Journal of Pathology 202, 145-156

83 A.B. Groeneveld (2002) Vascular pharmacology of acute lung injury and acute respiratory distress syndrome. Vascular Pharmacology 39, 247-256

84 L.B. Hinshaw , M.M. Jordan and J.A. Vick (1961) Histamine release and endotoxin shock in the primate. Journal of Clinical Investigation 40, 1631-1637

86 I. Breil (1997) Effects of bradykinin, histamine and serotonin on pulmonary vascular resistance and permeability. Acta Physiologica Scandinavica 159, 189-198

87 T.T. Bauer (2000) Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax 55, 46-52

88 J. Hamacher (2002) Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 166, 651-656

89 A.C. Windsor (1993) Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation. Journal of Clinical Investigation 91, 1459-1468

90 T. Geiser (2001) Pulmonary edema fluid from patients with acute lung injury augments in vitro alveolar epithelial repair by an IL-1beta-dependent mechanism. American Journal of Respiratory and Critical Care Medicine 163, 1384-1388

91 R.R. Gilmont (1998) Effects of glutathione depletion on oxidant-induced endothelial cell injury. Journal of Surgical Research 80, 62-68

92 Q. Wang (2007) Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROS. Free Radical Biology and Medicine 43, 1048-1060

94 C.C. Chua , R.C. Hamdy and B.H. Chua (1998) Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells. Free Radical Biology and Medicine 25, 891-897

95 T. Abumiya (2005) Aggravation of hemorrhagic transformation by early intraarterial infusion of low-dose vascular endothelial growth factor after transient focal cerebral ischemia in rats. Brain Research 1049, 95-103

96 M. Godzich (2006) Activation of the stress protein response prevents the development of pulmonary edema by inhibiting VEGF cell signaling in a model of lung ischemia-reperfusion injury in rats. FASEB Journal 20, 1519-1521

97 V. Nosal'ova (2008) Effect of H1 antihistamines in a model of mesenteric ischaemia/reperfusion. Inflammation Research 57 (Suppl 1), S55-56

98 C.D. Collard (1999) Complement activation following oxidative stress. Molecular Immunology 36, 941-948

99 D.L. Carden and D.N. Granger (2000) Pathophysiology of ischaemia-reperfusion injury. Journal of Pathology 190, 255-266

100 J. Hirahashi (2006) Mac-1 signaling via Src-family and Syk kinases results in elastase-dependent thrombohemorrhagic vasculopathy. Immunity 25, 271-283

101 J.S. Alexander and J.W. Elrod (2002) Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation. Journal of Anatomy 200, 561-574

102 J.M. Chehade , M.J. Haas and A.D. Mooradian (2002) Diabetes-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1) expression. Neurochemical Research 27, 249-252

103 M.K. Davidson (2000) Reduced expression of the adherens junction protein cadherin-5 in a diabetic retina. American Journal of Ophthalmology 129, 267-269

105 E. Bonnardel-Phu (1999) Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo. Diabetes 48, 2052-2058

106 K. Otero (2001) Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells. The Biochemical Journal 359, 567-574

107 A.M. Schmidt (2000) The biology of the receptor for advanced glycation end products and its ligands. Biochimica et Biophysica Acta 1498, 99-111

108 S. Yamagishi (2002) Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. Journal of Biological Chemistry 277, 20309-20315

109 M. Brownlee (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615-1625

110 E.O. Harrington (2003) Role of protein kinase C isoforms in rat epididymal microvascular endothelial barrier function. American Journal of Respiratory Cell and Molecular Biology 28, 626-636

111 J.H. Tinsley , N.R. Teasdale and S.Y. Yuan (2004) Involvement of PKCdelta and PKD in pulmonary microvascular endothelial cell hyperpermeability. American Journal of Physiology – Cell Physiology 286, C105-111

112 S.Y. Yuan (2000) Protein kinase C activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes. Circulation Research 87, 412-417

113 M. Guo (2003) Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes. Physiological Genomics 12, 139-146

114 R.B. Caldwell (2005) Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Current Drug Targets 6, 511-524

115 H. Hashizume (2000) Openings between defective endothelial cells explain tumor vessel leakiness. American Journal of Pathology 156, 1363-1380

116 S. Morikawa (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. American Journal of Pathology 160, 985-1000

117 J. Piulats and F. Mitjans (2008) Angiogenesis switch pathways. In Principles of Molecular Oncology (3rd edn) (Bronchud, M.H. et al.), pp. 239-256, Humana Press, Totowa, NJ, USA

118 K. Anan (1996) Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery 119, 333-339

120 F.Y. Lee (2008) Synergistic antitumor activity of ixabepilone (BMS-247550) plus bevacizumab in multiple in vivo tumor models. Clinical Cancer Research 14, 8123-8131

121 F. Yuan (1996) Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proceedings of the National Academy of Sciences of the United States of America 93, 14765-14770

122 M.H. Wu (2005) Endothelial focal adhesions and barrier function. Journal of Physiology 569, 359-366

123 H. Kargozaran (2007) A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier. Clinical and Experimental Metastasis 24, 495-502

124 K.L. Brigham , R.E. Bowers and P.J. Owen (1976) Effects of antihistamines on the lung vascular response to histamine in unanesthetized sheep. Diphenhydramine prevention of pulmonary edema and increased permeability. Journal of Clinical Investigation 58, 391-398

125 P.G. Cordeiro (2000) Prevention of ischemia-reperfusion injury in a rat skin flap model: the role of mast cells, cromolyn sodium, and histamine receptor blockade. Plastic and Reconstructive Surgery 105, 654-659

126 I.J. Elenkov (2004) Glucocorticoids and the Th1/Th2 balance. Annals of the New York Academy of Sciences 1024, 138-146

129 J. Zhang (2007) Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors. Cancer 109, 1478-1486

130 L.P. Aiello (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proceedings of the National Academy of Sciences of the United States of America 92, 10457-10461

132 C. Haritoglou (2006) Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26, 999-1005

133 C.E. Whittles (2002) ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity. Microcirculation 9, 513-522

134 G.P. van Nieuw Amerongen and V.W. van Hinsbergh (2002) Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascular Pharmacology 39, 257-272

135 J. Gavard , V. Patel and J.S. Gutkind (2008) Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Developmental Cell 14, 25-36

137 J.F. Dhainaut , S.B. Yan and Y.E. Claessens (2004) Protein C/activated protein C pathway: overview of clinical trial results in severe sepsis. Critical Care Medicine 32, S194-201

138 M. Riewald (2002) Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296, 1880-1882

139 J.S. Bae (2007) The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells. Blood 110, 3909-3916

140 C. Feistritzer and M. Riewald (2005) Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 105, 3178-3184

141 S. Kurosawa , C.T. Esmon and D.J. Stearns-Kurosawa (2000) The soluble endothelial protein C receptor binds to activated neutrophils: involvement of proteinase-3 and CD11b/CD18. Journal of Immunology 165, 4697-4703

142 N. Franscini (2004) Gene expression profiling of inflamed human endothelial cells and influence of activated protein C. Circulation 110, 2903-2909

143 D.E. Joyce (2001) Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis. Journal of Biological Chemistry 276, 11199-11203

144 S.S. Wong (2004) Drotrecogin alfa (activated) prevents smoke-induced increases in pulmonary microvascular permeability and proinflammatory cytokine IL-1beta in rats. Lung 182, 319-330

145 Z. Teke (2008) Activated protein C attenuates intestinal reperfusion-induced acute lung injury: an experimental study in a rat model. American Journal of Surgery 195, 861-873

146 L.P. Aiello (1997) Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46, 1473-1480

147 H. Ishii (1996) Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 272, 728-731

148 O. Koksel (2005) Rho-kinase (ROCK-1 and ROCK-2) upregulation in oleic acid-induced lung injury and its restoration by Y-27632. European Journal of Pharmacology 510, 135-142

149 M.F. Olson (2008) Applications for ROCK kinase inhibition. Current Opinion in Cell Biology 20, 242-248

150 L. Yin (2007) Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Molecular Cancer Therapeutics 6, 1517-1525

151 R. Arita (2009) Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage. Diabetes 58, 215-226

152 F. Peng (2008) RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease. Diabetes 57, 1683-1692

153 G.P. van Nieuw Amerongen (2000) Simvastatin improves disturbed endothelial barrier function. Circulation 102, 2803-2809

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Full text views

Total number of HTML views: 1
Total number of PDF views: 31 *
Loading metrics...

Abstract views

Total abstract views: 255 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 24th March 2017. This data will be updated every 24 hours.